Buying Retatrutide in the UK: What Researchers Need to Know About Sourcing, Purity and the Law
The short version: Retatrutide is an investigational triple agonist that has not been approved by the MHRA, the FDA, or any other regulatory agency. It is legally available only through Eli Lilly’s clinical trials. Anything sold to consumers or researchers outside that framework is an unapproved product, and the MHRA has been actively seizing illicit weight loss medicines in the UK. The MHRA has stated that, outside authorised clinical trials, any products sold in the UK that claim to contain retatrutide are likely to be illegal and potentially dangerous, and a research-use-only label does not change that. Alta Peptides publishes lot-specific certificates of analysis for every product configuration, which is the baseline standard any researcher should expect before ordering. Search for “buy retatrutide UK” and you will find a market that exists in a regulatory grey zone. The compound is not licensed as a medicine in the UK. It is…
